Procter & Gamble Company, The (PG)

$157.29

+0.33

(+0.21%)▲

Market is closed - opens 7 PM, 19 Apr 2024
star icon

Procter & Gamble Co is a consumer goods company that produces and sells a variety of household and personal care products, including Tide detergent, Pampers diapers, and Gillette razors.

Insights on Procter & Gamble Company, The

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 21.87B → 21.44B (in $), with an average decrease of 2.0% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 4.52B → 3.46B (in $), with an average decrease of 23.3% per quarter

  • Vs PEP

    In the last 3 years, Pepsico, Inc. has given 17.6% return, outperforming this stock by 3.2%

Performance

  • $156.01
    $157.56
    $157.29
    downward going graph

    0.81%

    Downside

    Day's Volatility :0.98%

    Upside

    0.17%

    downward going graph
  • $139.25
    $163.14
    $157.29
    downward going graph

    11.47%

    Downside

    52 Weeks Volatility :14.64%

    Upside

    3.59%

    downward going graph

Returns

PeriodProcter & Gamble Company, TheSector (Consumer Staples)Index (NASDAQ Composite)
3 Months
5.95%
1.5%
0.8%
6 Months
4.62%
7.9%
12.1%
1 Year
3.8%
-3.3%
11.1%
3 Years
14.9%
5.1%
10.4%

Highlights

Market Capitalization
367.0B
Book Value
$20.28
Dividend Share
3.735
Dividend Yield
2.58%
Earnings Per Share (EPS)
5.97
PE Ratio
26.12
PEG Ratio
3.28
Wall Street Target Price
170.37
Profit Margin
17.6%
Operating Margin TTM
27.42%
Return On Assets TTM
10.96%
Return On Equity TTM
31.78%
Revenue TTM
83.9B
Revenue Per Share TTM
35.57
Quarterly Revenue Growth YOY
3.2%
Gross Profit TTM
39.2B
EBITDA
23.7B
Diluted Eps TTM
5.97
Quarterly Earnings Growth YOY
-0.11
EPS Estimate Current Year
6.45
EPS Estimate Next Year
6.94
EPS Estimate Current Quarter
1.7
EPS Estimate Next Quarter
1.45

Analyst Recommendation

Buy
    66%Buy
    33%Hold
    0
    0%Sell
Based on 33 Wall street analysts offering stock ratings for Procter & Gamble Company, The(by analysts ranked 0 to 5 stars)
Based on 33 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
22
22
22
Hold
11
10
10
Sell
00
1
1

Analyst Forecast

What analysts predicted

Upside of 8.32%

Current $157.29
Target $170.37

Company Financials

FY18Y/Y Change
Revenue
66.8B
↑ 2.73%
Net Income
9.8B
↓ 36.38%
Net Profit Margin
14.59%
↓ 8.97%
FY19Y/Y Change
Revenue
67.7B
↑ 1.27%
Net Income
3.9B
↓ 60.03%
Net Profit Margin
5.76%
↓ 8.83%
FY20Y/Y Change
Revenue
71.0B
↑ 4.83%
Net Income
13.0B
↑ 234.28%
Net Profit Margin
18.36%
↑ 12.6%
FY21Y/Y Change
Revenue
76.1B
↑ 7.28%
Net Income
14.3B
↑ 9.82%
Net Profit Margin
18.79%
↑ 0.43%
FY22Y/Y Change
Revenue
80.2B
↑ 5.35%
Net Income
14.7B
↑ 3.05%
Net Profit Margin
18.38%
↓ 0.41%
FY23Y/Y Change
Revenue
82.0B
↑ 2.27%
Net Income
14.7B
↓ 0.6%
Net Profit Margin
17.87%
↓ 0.51%
Q3 FY22Q/Q Change
Revenue
20.6B
↑ 5.62%
Net Income
3.9B
↑ 29.06%
Net Profit Margin
19.11%
↑ 3.47%
Q4 FY22Q/Q Change
Revenue
20.8B
↑ 0.78%
Net Income
3.9B
↓ 0.15%
Net Profit Margin
18.93%
↓ 0.18%
Q1 FY23Q/Q Change
Revenue
20.1B
↓ 3.39%
Net Income
3.4B
↓ 13.63%
Net Profit Margin
16.93%
↓ 2.0%
Q2 FY23Q/Q Change
Revenue
20.6B
↑ 2.42%
Net Income
3.4B
↓ 0.38%
Net Profit Margin
16.46%
↓ 0.47%
Q3 FY23Q/Q Change
Revenue
21.9B
↑ 6.41%
Net Income
4.5B
↑ 33.6%
Net Profit Margin
20.67%
↑ 4.21%
Q4 FY23Q/Q Change
Revenue
21.4B
↓ 1.97%
Net Income
3.5B
↓ 23.29%
Net Profit Margin
16.17%
↓ 4.5%
FY18Y/Y Change
Total Assets
118.3B
↓ 1.74%
Total Liabilities
65.4B
↑ 1.24%
FY19Y/Y Change
Total Assets
115.1B
↓ 2.72%
Total Liabilities
67.5B
↑ 3.19%
FY20Y/Y Change
Total Assets
120.7B
↑ 4.87%
Total Liabilities
73.8B
↑ 9.34%
FY21Y/Y Change
Total Assets
119.3B
↓ 1.15%
Total Liabilities
72.7B
↓ 1.58%
FY22Y/Y Change
Total Assets
117.2B
↓ 1.76%
Total Liabilities
70.4B
↓ 3.16%
FY23Y/Y Change
Total Assets
120.8B
↑ 3.09%
Total Liabilities
73.8B
↑ 4.85%
Q3 FY22Q/Q Change
Total Assets
116.3B
↓ 0.79%
Total Liabilities
71.9B
↑ 2.27%
Q4 FY22Q/Q Change
Total Assets
117.7B
↑ 1.23%
Total Liabilities
73.0B
↑ 1.45%
Q1 FY23Q/Q Change
Total Assets
119.9B
↑ 1.81%
Total Liabilities
74.4B
↑ 1.97%
Q2 FY23Q/Q Change
Total Assets
120.8B
↑ 0.82%
Total Liabilities
73.8B
↓ 0.89%
Q3 FY23Q/Q Change
Total Assets
122.5B
↑ 1.41%
Total Liabilities
74.5B
↑ 1.02%
Q4 FY23Q/Q Change
Total Assets
120.7B
↓ 1.49%
Total Liabilities
71.9B
↓ 3.54%
FY18Y/Y Change
Operating Cash Flow
14.9B
↑ 16.58%
Investing Cash Flow
-3.5B
↓ 38.28%
Financing Cash Flow
-14.4B
↑ 67.78%
FY19Y/Y Change
Operating Cash Flow
15.2B
↑ 2.52%
Investing Cash Flow
-3.5B
↓ 0.6%
Financing Cash Flow
-10.0B
↓ 30.48%
FY20Y/Y Change
Operating Cash Flow
17.4B
↑ 14.18%
Investing Cash Flow
3.0B
↓ 187.25%
Financing Cash Flow
-8.4B
↓ 16.28%
FY21Y/Y Change
Operating Cash Flow
18.4B
↑ 5.56%
Investing Cash Flow
-2.8B
↓ 193.07%
Financing Cash Flow
-21.5B
↑ 157.33%
FY22Y/Y Change
Operating Cash Flow
16.7B
↓ 8.97%
Investing Cash Flow
-4.4B
↑ 56.1%
Financing Cash Flow
-14.9B
↓ 30.91%
FY23Y/Y Change
Operating Cash Flow
16.8B
↑ 0.75%
Investing Cash Flow
-3.5B
↓ 20.89%
Financing Cash Flow
-12.1B
↓ 18.35%
Q3 FY22Q/Q Change
Operating Cash Flow
4.1B
↑ 9.61%
Investing Cash Flow
-832.0M
↑ 21.99%
Financing Cash Flow
-3.5B
↓ 15.66%
Q4 FY22Q/Q Change
Operating Cash Flow
3.6B
↓ 12.19%
Investing Cash Flow
-490.0M
↓ 41.11%
Financing Cash Flow
-3.0B
↓ 14.66%
Q1 FY23Q/Q Change
Operating Cash Flow
3.9B
↑ 8.09%
Investing Cash Flow
-1.4B
↑ 181.63%
Financing Cash Flow
-1.8B
↓ 41.43%
Q2 FY23Q/Q Change
Operating Cash Flow
5.3B
↑ 38.26%
Investing Cash Flow
-798.0M
↓ 42.17%
Financing Cash Flow
-3.9B
↑ 122.08%
Q3 FY23Q/Q Change
Operating Cash Flow
4.9B
↓ 8.18%
Investing Cash Flow
-1.2B
↑ 53.13%
Financing Cash Flow
-2.0B
↓ 47.65%

Technicals Summary

Sell

Neutral

Buy

Procter & Gamble Company, The is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Procter & Gamble Company, The
Procter & Gamble Company, The
-2.64%
4.62%
3.8%
14.9%
48.01%
Pepsico, Inc.
Pepsico, Inc.
-1.04%
4.6%
-8.3%
17.08%
33.35%
Johnson & Johnson
Johnson & Johnson
-7.65%
-5.21%
-10.09%
-11.01%
5.27%
Coca-cola Company, The
Coca-cola Company, The
-2.69%
8.25%
-7.95%
8.35%
23.23%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Procter & Gamble Company, The
Procter & Gamble Company, The
26.12
26.12
3.28
6.45
0.32
0.11
0.03
20.28
Pepsico, Inc.
Pepsico, Inc.
25.49
25.49
2.78
8.16
0.51
0.09
0.03
13.47
Johnson & Johnson
Johnson & Johnson
27.78
27.78
0.89
10.65
0.18
0.08
0.03
28.57
Coca-cola Company, The
Coca-cola Company, The
23.51
23.51
2.93
2.81
0.4
0.09
0.03
6.02
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Procter & Gamble Company, The
Procter & Gamble Company, The
Buy
$367.0B
48.01%
26.12
17.6%
Pepsico, Inc.
Pepsico, Inc.
Buy
$230.2B
33.35%
25.49
9.92%
Johnson & Johnson
Johnson & Johnson
Hold
$348.1B
5.27%
27.78
41.28%
Coca-cola Company, The
Coca-cola Company, The
Buy
$250.7B
23.23%
23.51
23.42%

Institutional Holdings

  • Vanguard Group Inc

    9.56%

  • BlackRock Inc

    6.62%

  • State Street Corporation

    4.38%

  • Morgan Stanley - Brokerage Accounts

    2.07%

  • Geode Capital Management, LLC

    2.00%

  • Wellington Management Company LLP

    1.46%

Corporate Announcements

  • Procter & Gamble Company, The Dividends March,2024

    In the quarter ending March,2024. Procter & Gamble Company, The has declared dividend of $0.94

    Read More

Company Information

The Procter & Gamble Company is an American multinational consumer goods corporation headquartered in Cincinnati, Ohio, founded in 1837 by William Procter and James Gamble.

Organization
Procter & Gamble Company, The
Employees
107000
CEO
Mr. Jon R. Moeller
Industry
Consumer Non-Durables

Discover More

FAQs